<PAGE>
EXHIBIT 23.1
[KPMG LETTERHEAD]
CONSENT OF INDEPENDENT AUDITORS
The Board of Directors
Calypte Biomedical Corporation:
We consent to the incorporation by reference herein of our reports dated
March 9, 2000, relating to the consolidated balance sheets of Calypte Biomedical
Corporation and subsidiary as of December 31, 1999 and 1998, and the related
consolidated statements of operations, stockholders' equity, and cash flows for
each of the years in the three-year period ended December 31, 1999, and the
related schedule, which reports appear in the December 31, 1999 annual report on
Form 10-K of Calypte Biomedical Corporation, and to the reference to our firm
under the heading "Experts" and "Risks Factors" in this Form S-3 filling.
Our reports dated March 9, 2000 contain an explanatory paragraph that states
that the Company has suffered recurring losses from operations and has an
accumulated deficit that raise substantial doubt about its ability to continue
as a going concern. The consolidated financial statements and the financial
statement schedule do not include any adjustments that might result from that
uncertainty.
/s/ KPMG LLP
San Francisco, California
December 14, 2000
